Clene (CLNN) Tax Provisions (2021 - 2025)
Clene (CLNN) posted Tax Provisions of -$5.5 million for Q4 2025, up 33.54% on a QoQ basis from -$8.3 million in Q4 2024, and up 33.54% year-over-year from -$4.1 million in Q4 2024.
Analysis
Clene (CLNN) Tax Provisions (2021 - 2025) Analysis & Trends
Clene has reported Tax Provisions for 5 years, with the latest figure at -$5.5 million in Q4 2025.
- On a quarterly basis, Tax Provisions rose 33.54% year-over-year to -$5.5 million in Q4 2025; TTM through Jun 2026 was -$5.5 million, a 33.54% increase from a year earlier, with the FY2025 full-year figure at -$5.5 million, up 33.54% from the prior year.
- Tax Provisions was -$5.5 million for Q4 2025 at Clene, up from -$8.3 million in the prior quarter.
- The five-year high for Tax Provisions was -$69000.0 in Q3 2021, with the low at -$10.4 million in Q4 2023.
- Average Tax Provisions over 5 years is -$4.1 million, with a median of -$3.7 million recorded in 2021.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions slumped 226.85% in 2022, then soared 33.54% in 2025.
- Over 5 years, Tax Provisions stood at -$1.9 million in 2021, then plunged by 226.85% to -$6.3 million in 2022, then sank by 65.28% to -$10.4 million in 2023, then grew by 20.35% to -$8.3 million in 2024, then jumped by 33.54% to -$5.5 million in 2025.
- The last three Tax Provisions figures came in at -$5.5 million (Q4 2025), -$8.3 million (Q4 2024), and -$10.4 million (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | -407.00 Mn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | -524.23 Mn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 165.91 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 39.70 Mn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2024 | -8.27 Mn |
| Dec 31, 2023 | -10.38 Mn |
| Dec 31, 2022 | -6.28 Mn |
| Dec 31, 2021 | -1.92 Mn |
| Sep 30, 2021 | -69,000.00 |
| Jun 30, 2021 | -72,000.00 |
| Mar 31, 2021 | -72,000.00 |